References
- Na HR, Kang EH, Lee JH, et al. The genetic basis of panic disorder. J Korean Med Sci. 2011;26:701–710.
- Maron E, Hettema JM, Shlik J. Advances in molecular genetics of panic disorder. Mol Psychiatry. 2010;15:681–701.
- Rall SC Jr, Mahley RW. The role of apolipoprotein E genetic variants in lipoprotein disorders. J Intern Med. 1992;231:653–659.
- Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507–537.
- Cuthbert JA, Lipsky PE. Provision of cholesterol to lymphocytes by high density and low density lipoproteins. Requirement for low density lipoprotein receptors. J Biol Chem. 1987;262:7808–7818.
- Xhignesse M, Lussier-Cacan S, Sing CF, et al. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb. 1991;11:1100–1110.
- Karim S, Burns A. The biology of psychosis in older people. J Geriatr Psychiatry Neurol. 2003;16:207–212.
- Isbir T, Agaçhan B, Yilmaz H, et al. Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2001;16:205–210.
- Hohman TJ, Dumitrescu L, Oksol A, et al. APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer’s Disease; Alzheimer’s Disease Neuroimaging Initiative. PLoS One. 2017;12:e0188501.
- Feng F, Lu SS, Hu CY, et al. Association between apolipoprotein E gene polymorphism and depression. J Clin Neurosci. 2015;22:1232–1238.
- Rajan KB, Wilson RS, Skarupski KA, et al. Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon} 4 allele on cognitive decline. Psychosom Med. 2014;76:101–108.
- Gatt JM, Burton KL, Williams LM, et al. Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J Psychiatr Res. 2015;60:1–13.
- Mahley RW, Palaoğlu KE, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res. 1995;36:839–859.
- Hoefner DM, Hodel SD, O’Brien JF, et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem. 2001;47:266–274.
- Oravec S, Dukat A, Gavornik P, et al. Atherogenic versus non-atherogenic lipoprotein profiles in healthy individuals. Is there a need to change our approach to diagnosing dyslipidemia?. Curr Med Chem. 2014;21:2892–2901.
- Martínez-Barrondo S, Sáiz PA, Morales B, et al. Negative evidences in association between apolipoprotein E polymorphism and panic disorder. Eur Psychiatry. 2006;21:59–61.
- Zhu H, Xue H, Wang H, et al. The association of apolipoprotein E (APOE) gene polymorphisms with atherosclerosis susceptibility: a meta-analysis. Minerva Cardioangiol. 2016;64:47–54.
- Mastroianno S, Di Stolfo G, Seripa D, et al. Role of the APOE polymorphism in carotid and lower limb revascularization: a prospective study from Southern Italy. PLoS One. 2017;12:e0171055.
- Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622–630.
- Isbir T, Agaçhan B, Yilmaz H, et al. Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2001;16:77–81.
- Damoiseaux JS, Seeley WW, Zhou J, et al. Gender modulates the APOE E4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J Neurosci. 2012;32:8254–8262.
- Chen HK, Liu Z, Meyer-Franke A, et al. Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem. 2012;287:5253–5266.
- Correa DD, Satagopan J, Baser RE, et al. APOE polymorphisms and cognitive functions in patients with brain tumors. Neurology. 2014;83:320–327.
- Ahles TA, Saykin AJ, Noll WW, et al. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology. 2003;12:612–619.
- Nathan BP, Bellosta S, Sanan DA, et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994;264:850–852.
- Ryan L, Walther K, Bendlin BB, et al. Age-related differences in white matter integrity and cognitive function are related to APOE status. Neuroimage. 2011;54:1565–1577.
- Harrington CR, Roth M, Xuereb JH, et al. Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci Lett. 1995;202:101–104.
- Xu MQ, St Clair D, He L. Meta-analysis of association between ApoE epsilon4 allele and schizophrenia. Schizophr Res. 2006;84:228–235.
- Castellano JM, Kim J, Stewart FR, et al. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med. 2011;3:89ra57.
- Liao F, Yoon H, Kim J. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer’s disease. Curr Opin Lipidol. 2017;28:60–67.
- Giau VV, Bagyinszky E, An SS, et al. Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatr Dis Treat. 2015;11:1723–1737.
- Papakostas GI, Ongür D, Iosifescu DV, et al. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol. 2004;14:135–142.
- Coryell W, Noyes R, Jr, House JD. Mortality among outpatients with anxiety disorders. Am J Psychiatry. 1986;143:508–510.
- Hayward C, Taylor CB, Roth WT, et al. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry. 1989;146:917–919.
- Feder R. High cholesterol levels in patients with panic disorder. AJP. 1993; 150:527c.
- Lacerda AL, Caetano D, Caetano SC. Cholesterol levels in panic disorder, generalized anxiety disorder and major depression. Arq Neuropsiquiatr. 2000;58:408–411.
- Palinkas LA, Barrett-Connor E, Morgan RE, et al. Serum lipids and depression. Lancet. 1993;341:563.
- Partonen T, Haukka J, Virtamo J, et al. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry. 1999;175:259–262.
- Han S, Xu Y, Gao M, et al. Serum apolipoprotein E concentration and polymorphism influence serum lipid levels in Chinese Shandong Han population. Medicine (Baltimore). 2016;95:e5639.
- Aydogan HY, Isbir S, Kurnaz O, et al. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease. In Vivo. 2009;23:155–161.
- Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005;96:1221–1232.
- Leon AS, Togashi K, Rankinen T, et al. Association of apolipoprotein E polymorphism with blood lipids and maximal oxygen uptake in the sedentary state and after exercise training in the HERITAGE Family Study. Metabolism. 2004;53:108–116.
- Benton JL, Blumenthal RS, Becker DM, et al. Predictors of low-density lipoprotein particle size in a high-risk African-American population. Am J Cardiol. 2005;95:1320–1323.
- Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 1987;113:589–597.
- Rubinsztein DC. Apolipoprotein E: a review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer’s disease. Psychol Med. 1995;25:223–230.